Contineum Therapeutics (CTNM) Change in Acquisitions & Divestments (2023 - 2026)

Contineum Therapeutics' Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $58.1 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 19.46% year-over-year to $58.1 million; the TTM figure through Mar 2026 stood at $168.5 million (up 1.32% YoY), while the FY2025 annual figure was $159.0 million, up 1.18% from the prior year.
• Change in Acquisitions & Divestments was $58.1 million for Q1 2026 at Contineum Therapeutics, up from $37.3 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $58.1 million in Q1 2026 to a low of $12.6 million in Q3 2023.
• Historically, Change in Acquisitions & Divestments has averaged $34.7 million across 4 years, with a median of $37.3 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments surged 235.53% in 2024, then dropped 20.35% in 2025.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $31.3 million in 2023, then jumped by 44.03% to $45.1 million in 2024, then fell by 17.3% to $37.3 million in 2025, then jumped by 55.73% to $58.1 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $58.1 million (Q1 2026), $37.3 million (Q4 2025), and $33.7 million (Q3 2025), per Business Quant data.